This is a news story, published by Sky News, that relates primarily to Casgevy news.
For more Casgevy news, you can click here:
more Casgevy newsFor more medical innovations news, you can click here:
more medical innovations newsFor more news from Sky News, you can click here:
more news from Sky NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like medical innovations news, you might also like this article about
clinical benefit. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest dependent beta thalassaemia news, fewer transfusions news, medical innovations news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
regular blood transfusionsSky News
•79% Informative
Casgevy uses 'molecular scissors' to disable a faulty gene that causes beta-thalassaemia.
Currently people need blood transfusions every few weeks because their own red blood cells are unable to carry enough oxygen around the body.
In trials 90% of people were effectively cured by a single treatment.
The National Institute for Health and Care Excellence (NICE) said in new final draft guidance that the treatment will be made available on the NHS .
VR Score
79
Informative language
78
Neutral language
65
Article tone
semi-formal
Language
English
Language complexity
61
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links